HPTN 039-01

Ancillary Study: Prospective Cohort Study of HPTN 039 Seroconverters: The Effect of HSV-2 Suppression on HIV-1 Viral Set Point

Study Summary

What was HPTN 039-01?

A prospective multi-site cohort study to determine the effect of HSV-2 suppression with twice-daily acyclovir during the first six months after HIV acquisition on HIV viral set point.

Who participated in the study?

Women and men who have sex with men (WSM, MSM)

What happened during the study?

Acyclovir 400 mg po bid or matching placebo po bid (continuation of HPTN 039 treatment).